About Us

Doing now what patients need next.

Roche Diagnostics develops and produces medical tests and digital tools that provide information to help healthcare professionals find the right treatment for patients and deliver the best patient care to improve, prolong and save lives. Currently, Roche Diagnostics leads the industry in developing diagnostic products for cancer, cardiac health, infectious diseases, women’s health and diabetes management.

Our North American headquarters for Roche Diagnostics Corporation is located in Indianapolis, IN. We have been part of the Indianapolis community since 1964 when Bio-Dynamics was founded. Boehringer Mannheim Corporation acquired Bio-Dynamics in 1974. Roche acquired Boehringer in 1998 and, within three years, became a world leader in diagnostics.

Today, we have sites across the U.S., focusing on different areas like research and development, laboratory, manufacturing, distribution, information technology and administrative operations.

The world needs better methods to diagnose, prevent and treat diseases. As demands on healthcare systems are changing more than ever, healthcare must be delivered efficiently.

As the world leader in healthcare research and development, we strive to bring cutting-edge diagnostic solutions to patients across the United States. Our approach is to support patients and providers with diagnostics solutions, decision support and disease management.

In 2024, Roche Diagnostics was recognized with six IMV ServiceTrak Clinical Laboratory Awards across the categories of Customer Satisfaction, System Performance and Service for Chemistry and Integrated Workstation systems.

Our business areas

We develop diagnostic tests, instruments and digital solutions with the power to transform healthcare for people around the U.S. Learn more about our business partners and patents.

Our health topics

We focus on diseases with high medical needs, such as cardiometabolic, sexual health, respiratory, infectious diseases, oncology and Alzheimer’s disease. We partner with medical laboratories to help physicians more accurately deliver treatments to patients who are likely to benefit.

Alzheimer's Disease

Early diagnosis of Alzheimer’s can lead to measures that help preserve cognitive function, prolong independent living, and improve quality of life, symptom management and the efficacy of disease-modifying therapies.

Oncology

Every cancer is unique. Throughout each person’s journey, diagnostic testing helps uncover critical insights that support better outcomes.

Sexual Health

Sexually transmitted infections are on the rise. Having access to screening and diagnostic testing is often the first line of defense. The impact of diagnostics and innovative testing can transform STIs into manageable conditions.

Women's Health

From cervical cancer screening to support in fertility, prenatal testing and pregnancy care to breast and ovarian cancer diagnosis to managing bone health, Roche is the trusted diagnostic partner that healthcare providers can depend on.

Improving patients' lives for more than a century

We’re built on a foundation of integrity, innovation and passion. Our story has taken shape over more than a century; today, we continue in our quest to help patients live longer, healthier lives.

We welcome you to explore our key milestones and learn how we have grown into a healthcare leader.

At Roche, people are at the heart of what we do. We are committed to a culture where everyone feels a sense of belonging and where everyone can thrive, regardless of age, background, beliefs, ability or perspective. Our inclusive culture is long-term orientated, helping us achieve our purpose, drive better business outcomes and collectively make the impossible possible for patients.

Our values

Integrity

We are consistently open, honest, ethical and genuine.

Courage

We are entrepreneurial and thus take risks, reach beyond boundaries and experiment.

Passion

We use our drive and commitment to energize, engage and inspire others.

IMV ServiceTrak Awards
- Integrated Systems: Best Customer Satisfaction (2024, 2025), Best System Performance (2024, 2025), Best Service (2024, 2025)
- Chemistry: Best Customer Satisfaction (2024, 2025), Best System Performance (2024, 2025), Best Service (2024, 2025)
- Immunoassay: Best Customer Satisfaction (2025)
TIME
- Best Inventions, 2024: HPV self-collection solution (Winner); pTau217 assay (Special Mention)
- Best Employers for Future Leaders: 2024
LinkedIn
- Top 50 Companies: 2025 (Ranked No. 22)
Glassdoor
- Top 100 U.S. Best Places to Work (2022, 2025, 2026);
- No. 7 in Healthcare, Biotech and Pharma (new in 2026)
Tucson (Arizona) Top Workplaces: Top Leadership, 2023
Human Rights Campaign Foundation
- Equality 100 Award: Leader in LGBTQ+ Workplace Inclusion: 2023, 2024, 2025
- Best Place to Work for LGBTQ Equality: 2020, 2021, 2022
FAIR360
- Top 50 Companies for Workplace Fairness: 2024
- Top Noteworthy Employers: 2023
Military Friendly Employer
- Ranked No. 1: 2025
- Designated Employer: 2017–2025
National Organization for Disability
- Leading Disability Employers: 2023
Indiana Department of Labor / Indiana OSHA
- Voluntary Protection Program: 2025
Dow Jones Sustainability Indices
- Index Member: 2009–2023

Latest culture stories

Our purpose is to do now what patients need next. We’re able to achieve our purpose by creating a holistic approach that integrates three dimensions of sustainability.

Sustainability Roadmap

Beyond emissions targets and updated packaging, our three-pillar mapping drives healthcare innovation without compromising the future of our planet.

Learn more

Society

We contribute to a better society by enabling the right treatment for the right patient at the right time for the right value. We do this by developing new medicines and ways of diagnosing diseases and insights from data.

Environment

Respect for a healthy planet and the environment has always been a priority of our founding families and the company. We are committed to halving the environmental impact of our operations and products from 2019 to 2029.

Economy

Our business must meet the needs of patients and continue creating high-quality jobs that provide people and their families with secure livelihoods, while earning competitive returns for our investors. Learn more about our culture.

California SB 261 Climate-Related Financial Risk Report – Roche Diagnostics Corporation is a member of the Roche Group, and its operations are encompassed in the Roche Group’s latest Sustainability Report included in the Roche Group’s Annual Report. For Roche Diagnostics Corporations’ SB 261 disclosure, please see Chapter 6 of the Roche Group’s Sustainability Report “Task Force on Climate-related Financial Disclosures (TCFD)” at pages 117- 126 of the Annual Report 2024.